Between February 2025 and February 2026, the commercial pharmaceutical sector reported a roughly 20 percent increase in enterprise value. Meanwhile, the biotechnology subsector experienced a five percent decrease in aggregate enterprise value.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Stifel. (February 9, 2026). Change in aggregate enterprise value by biopharma subsectors worldwide for 2025 and 2026 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 19, 2026, from /statistics/1244525/enterprise-value-changes-of-biopharma-subsectors/
Stifel. "Change in aggregate enterprise value by biopharma subsectors worldwide for 2025 and 2026." Chart. February 9, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 19, 2026. /statistics/1244525/enterprise-value-changes-of-biopharma-subsectors/
Stifel. (2026). Change in aggregate enterprise value by biopharma subsectors worldwide for 2025 and 2026. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 19, 2026. /statistics/1244525/enterprise-value-changes-of-biopharma-subsectors/
Stifel. "Change in Aggregate Enterprise Value by Biopharma Subsectors Worldwide for 2025 and 2026." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 9 Feb 2026, /statistics/1244525/enterprise-value-changes-of-biopharma-subsectors/
Stifel, Change in aggregate enterprise value by biopharma subsectors worldwide for 2025 and 2026 ÌÇÐÄÆƽâ°æ, /statistics/1244525/enterprise-value-changes-of-biopharma-subsectors/ (last visited July 19, 2026)
Change in aggregate enterprise value by biopharma subsectors worldwide for 2025 and 2026 [Graph], Stifel, February 9, 2026. [Online]. Available: /statistics/1244525/enterprise-value-changes-of-biopharma-subsectors/
